Femasys Inc financial data

Symbol
FEMY on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
3950 Johns Creek Court, Suite 100, Suwanee, GA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 654 % -10.7%
Quick Ratio 45.5 % +39.7%
Debt-to-equity 71.9 % +306%
Return On Equity -141 % -41.5%
Return On Assets -82.3 % +3.14%
Operating Margin -1.39K % -16.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 22.9M shares +5.77%
Common Stock, Shares, Outstanding 22.2M shares +39%
Entity Public Float 6.83M USD -70.5%
Common Stock, Value, Issued 22.4K USD +38.7%
Weighted Average Number of Shares Outstanding, Basic 22.2M shares +47.3%
Weighted Average Number of Shares Outstanding, Diluted 22.2M shares +47.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.26M USD +15.3%
Research and Development Expense 8.12M USD +26.7%
Selling and Marketing Expense 3.05M USD +291%
General and Administrative Expense 6.86M USD +13.4%
Operating Income (Loss) -17.5M USD -34.1%
Nonoperating Income (Expense) -587K USD -275%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5.41M USD -35.3%
Income Tax Expense (Benefit) 1.16K USD
Net Income (Loss) Attributable to Parent -18.1M USD -42.2%
Earnings Per Share, Basic -0.82 USD/shares +16.3%
Earnings Per Share, Diluted -0.82 USD/shares +16.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.61M USD -12.4%
Accounts Receivable, after Allowance for Credit Loss, Current 378K USD +265%
Inventory, Net 1.94M USD +222%
Other Assets, Current 1.37M USD +65.8%
Assets, Current 11.3M USD +10.5%
Property, Plant and Equipment, Net 1.39M USD +19.6%
Operating Lease, Right-of-Use Asset 2.38M USD +673%
Other Assets, Noncurrent 887K USD -5.29%
Assets 15.6M USD +4.93%
Accounts Payable, Current 1.12M USD +31.7%
Employee-related Liabilities, Current 1.08M USD +1171%
Accrued Liabilities, Current 1.13M USD +98%
Liabilities, Current 2.87M USD +31.1%
Operating Lease, Liability, Noncurrent 2.04M USD +7023%
Liabilities 9.62M USD +118%
Retained Earnings (Accumulated Deficit) -122M USD -17.4%
Stockholders' Equity Attributable to Parent 5.97M USD -42.8%
Liabilities and Equity 15.6M USD +4.93%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.57M USD -72.5%
Net Cash Provided by (Used in) Financing Activities 778K USD
Net Cash Provided by (Used in) Investing Activities -90.2K USD -913%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 22.4M shares +38.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.61M USD -12.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 26M USD +15%
Deferred Tax Assets, Gross 26.6M USD +16.9%
Operating Lease, Liability 2.44M USD +532%
Depreciation 70K USD -46.8%
Payments to Acquire Property, Plant, and Equipment 64.6K USD +625%
Property, Plant and Equipment, Gross 5.14M USD +8.03%
Operating Lease, Liability, Current 407K USD +13.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 629K USD +1238%
Lessee, Operating Lease, Liability, to be Paid, Year One 452K USD -19%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 655K USD
Deferred Tax Assets, Operating Loss Carryforwards 19.7M USD +10.1%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 681K USD
Operating Lease, Payments 3.32M USD
Additional Paid in Capital 125M USD +11.2%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.25K USD -11.9%
Share-based Payment Arrangement, Expense 359K USD -48.2%
Interest Expense 525K USD +4135%